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Understanding HIV Positive Patients’ Perspectives on Opt-Out, Incentivized, and Mandatory 
HIV Testing 
Sirena Sun 





Background: In the absence of a successful HIV vaccine, widespread HIV testing remains the 
best preventive action against further spread of the HIV epidemic. However, over 40% of the 
U.S. population has never been tested for HIV. To increase testing rates, in 2006 the CDC 
advised healthcare settings to conduct testing on an opt-out basis.  
 
Objective: Qualitative, semi-structured interviews were conducted to address the lack of 
studies investigating patients’ acceptance of and attitude towards this and more novel testing 
models, e.g. incentivized or anonymous mandatory testing.  
 
Methods: Ten HIV-positive patients aged 18-64 were interviewed. Participants were asked 
about their HIV testing history and attitudes towards opt-out, incentivized, and mandatory 
anonymous HIV testing. Other ways to improve U.S. HIV testing rates were also explored. 
Major themes were identified using grounded theory data analysis. 
 
Results: All participants were receptive to opt-out testing, and saw the removal of separate 







some form. Participants still preferred providing counseling either before or after the test as a 
form of support. Participants were supportive of incentivized testing as a pragmatic measure 
to entice people to test, but felt that ideally these coercive measures shouldn’t be needed to 
encourage individuals to look after their own health. Participants were supportive of 
mandatory testing with consideration for confidentiality of test results. Ultimately, both 
mandatory and opt-out testing were equally indicated by participants as being the most 
effective testing model at increasing testing rates. Some participants wanted testing to be 
mandatory but did not feel that it was a feasible testing initiative because it would never be 
implemented due to overwhelming resistance.  
 
Conclusion: A firm understanding of patients’ perspectives allows for development of 
effective HIV testing initiatives that are patient-sensitive and can substantially reduce HIV 
infection rates. Future testing initiatives must also be coupled with sufficient linkage to care 








CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
 
1.1. The HIV/AIDS Epidemic in the United States 
 Currently over one million people are living with HIV/AIDS in the United States. 
Moreover, every 9 ½ minutes someone is infected with HIV (Kaiser Family Foundation, 
2009a). Though advances in treatment have helped improve the quality of life for people 
living with HIV/AIDS (PLWHA) and prevent AIDS-related morbidity and mortality, the 
HIV/AIDS epidemic continues to be a significant public health problem. A recent report by 
the CDC indicated that 56,300 new HIV infections occurred in 2006, a number that was 40% 
higher than the previous CDC estimate of 40,000 infections per year (CDC, 2008).  
 
1.2. Centers for Disease Control HIV Testing Recommendations 
The importance of HIV testing as a method for preventing further spread of the 
disease has always been recognized and reflected in the CDC’s recommendations throughout 
the HIV epidemic in the U.S. Routine voluntary counseling and testing (VCT) was first 
recommended by the CDC in 1987. At the time, testing was recommended for those 
considered high-risk groups: homosexual males, IV-drug users, hemophiliacs, sexual and/or 
needle-sharing partners of these individuals, and patients of sexually transmitted disease 
(STD) clinics. The recommendations also stressed the importance of counseling in helping 
uninfected individuals initiate and sustain health behaviors that reduce their risk for infection 
and helping infected individuals cope with their diagnoses and learn ways to avoid 
transmitting the disease to others (CDC, 1987). Over time, the CDC expanded its VCT 
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recommendations to include hospitalized patients and outpatients receiving care in acute-care 
settings (e.g. the emergency department) (CDC, 1993), and pregnant women (CDC, 1995).  
 In 2006, the CDC shifted from risk-based VCT to routine, opt-out testing. Under 
these new recommendations, all healthcare settings should screen all patients between the 
ages of 13 to 64 on a routine basis. Testing is no longer done based on presence of risk 
factors. In opt-out testing, patients are informed that they will be given an HIV test and 
consent is implied unless they specifically decline, or “opt-out” of the test. Moreover, 
separate written consent and pretest counseling requirements are no longer recommended. 
The updated testing recommendations for pregnant women include a second test for at-risk 
women during their third trimester of pregnancy, opt-out testing for women with 
undocumented HIV status during labor and delivery, and testing of newborns of mothers with 
unknown HIV status. Table 1 in Appendix A further outlines these testing recommendations. 
These recommendations apply to all healthcare settings including inpatient services, 
emergency departments, and urgent care, STD, tuberculosis, public health, community, 
substance abuse, and corrections facility clinics. For healthcare settings with low or unknown 
HIV prevalence, universal screening should be conducted until the prevalence of HIV has 
been determined. If the prevalence is less than 0.001%, universal screening can be 
discontinued and other provisions can be made depending on the conditions of the healthcare 
setting.   
 
1.2.1 Rationale for Updated HIV Testing Recommendations 
The CDC changes in HIV testing recommendations were created to increase the 





becoming less effective at identifying undiagnosed HIV positive individuals due to the 
changing epidemiology of the HIV epidemic. Moreover, the existence of pretest 
requirements under VCT was seen as a barrier to testing. Written informed consent and 
pretest counseling requirements were removed to facilitate the testing process.  
Originally, VCT testing was conducted based on the presence of risk factors: 
injection drug use, unprotected sex with men who have sex with men (MSM) or multiple 
partners, exchanging sex for money, and being diagnosed with or receiving treatment for 
tuberculosis (TB), hepatitis or STDs. However, these risk-based methods are no longer 
effective at identifying potentially undiagnosed HIV positive individuals. Though MSM do 
continue to be significantly affected by the disease (48% of new HIV infections in 2006), 
racial/ethnic minorities, women, and MSM subgroups are an increasing proportion of 
infected individuals; women account for 27% of new infections (CDC 2008).  
Moreover, racial/ethnic minorities are disproportionately affected by HIV/AIDS 
(Figure 1, Appendix B). Though African-Americans only comprise 12% of the U.S. 
population, they comprise 45% of all new cases of HIV infections while whites consist of 
66% of the U.S. population but only comprise 35% of new HIV infections (Kaiser Family 
Foundation, 2009a). 
The CDC also recommended all healthcare settings to conduct routine testing to 
increase the yield of testing initiatives. Studies indicate that the healthcare settings in which 
people are most likely to get an HIV test are not the same settings in which they are most 
likely to receive a positive diagnosis. For example, most HIV tests (44%) are conducted in 
private healthcare settings, such as a primary care physician’s office, but comprise only 17% 





hospitals and emergency departments (ED) (27%) and community clinics (21%), while these 
settings only conduct 22% and 9% of tests, respectively (Janssen, 2007). These results 
indicate that most individuals receive HIV testing when they are seeking other healthcare 
services.  
 
1.2.2 Current Implementation of CDC Recommendations 
State laws remain a considerable obstacle to full compliance with CDC HIV testing 
recommendations. One of the key components of the CDC recommendations for routine, opt-
out testing is the removal of separate written consent requirements. However, in the two 
years since the release of the CDC recommendations, nine states still have laws mandating 
separate written informed consent (Mahajan et al., 2009). Nine states allow for opt-out and 
general consent for medical care, three states do not specify opt-out consent mechanisms but 
allow for general consent for care to cover consent for HIV testing. Though these data 
indicate that most states are compliant with CDC recommendations, it is crucial that all states 
are conducting opt-out testing and their legislation does not impede implementation of opt-
out testing initiatives.  
 
 
1.3 Current Examples of Novel Testing Initiatives 
1.3.1 Incentivized Testing 
In addition to opt-out testing, alternative forms of HIV testing have been in use on a 
limited basis. Incentivized testing is a recent testing initiative where a small incentive (e.g. 





individuals to take the test. One study offered a $25 incentive to patients who adhered with 
their emergency room referrals to outpatient HIV testing (Haukoos et al., 2005). The 
California Prevention and Education Project offers $10 Safeway vouchers to individuals who 
complete an HIV test (Maher, 2008).  
 
1.3.2 Mandatory Testing 
Mandatory testing has also emerged as another alternative testing method for certain 
groups of individuals and situations such as pregnant women, federal prisoners, active duty 
personnel, and the testing of blood/organ donations (Kaiser Family Foundation, 2008b). 
 Currently, 17 states have legislation requiring mandatory HIV testing for pregnant 
women. If the mother refuses, her refusal will be noted and the newborn will automatically 
be tested. (Kaiser Family Foundation, 2008a). Exceptions are only made on religious 
grounds.  
Several states also have implemented laws mandating testing of prisoners. For 
example, on February 2, 2007 the Texas Attorney General Greg Abbott ruled that state law 
allows the Texas prison system to mandate HIV testing for all inmates upon entry to any state 
prison unless they decline testing (Kaiser Daily HIV/AIDS Report, 2007a). Moreover, in 
September 2007, the Senate passed a bill (HR 1943) mandating HIV testing of all prisoners 
upon entry to and exit from any federal prison. Inmates would be allowed to opt-out of 
testing unless exposed to an HIV risk, such as pregnancy or a sexual encounter during 







1.4 Existing Literature on Patients’ Perspectives on HIV Testing Models 
1.4.1 Patients’ Perspectives on Opt-Out Testing 
Though these different types of testing initiatives have been implemented to limited 
degrees with the goal of increasing testing rates, few studies have investigated patients’ 
perspectives on these testing initiatives. Haukoos et al. (2008) surveyed patients’ opinion on 
opt-out testing in the ED of an urban safety-net public hospital. Over a three-month period, 
529 patients were surveyed. 93% of patients would have agreed to take an HIV test if their 
physician had recommended it during their emergency room visit. However, it is important to 
make note that patients’ responses were hypothetical because they were not actually offered 
an HIV test in this study.  
Burrage et al. (2008) surveyed 30 women attending three urban community health 
clinics in Indianapolis on their opinions toward opt-out screening. The majority of 
respondents (80%) believed that opt-out testing was beneficial. However, seventeen (56.7%) 
participants felt that post-test counseling should not be eliminated. Corneli et al. (2008) 
examined the perspective of TB patients on three different types of routine provider-initiated 
HIV testing. The majority of participants were receptive to provider-initiated testing. 
However, because this study still maintained pre-test requirements, its results may not be 
applicable to opt-out testing that completely complies with the CDC’s 2006 
recommendations.  
 
1.4.2. Patients’ Perspectives on Incentivized Testing 
Current available literature has not addressed patients’ attitude towards incentivized 





behaviors, such as following up on outpatient HIV testing referrals from the ED and 
encouraging adherence with HIV treatment regimens.  
In one study conducted by Haukoos et al. (2005), 372 participants were provided 
outpatient HIV counseling and testing referrals. These participants were identified for testing 
based upon the VCT testing guidelines of the CDC. Testing referrals were done in three 
segments. In the first and third segment, no incentives were offered. In the second period, a 
$25 incentive was offered for completion of the outpatient testing and counseling referral. 
During the two control periods, only a total of 8% of participants completed the testing 
referral while 23% of participants offered incentives completed counseling and testing. 
Another study examined incentivizing treatment compliance for HIV-positive 
methadone patients who had a documented compliance rate of less than 80% (Barnett et al., 
2009). Participants were randomized into either the control group receiving medication 
coaching or the intervention group where vouchers of increasing monetary value were 
provided for sustained treatment compliance. Adherence was measured by on-time opening 
of an electronically monitored medication vial. Perfect treatment compliance would result in 
the participant receiving a maximum of $1172 in vouchers over the duration of the 
intervention. The intervention group had a compliance of 78% versus 56% in the control 
group.   
 
1.4.3. Patients’ Perspectives on Mandatory Testing 
One study examined patient perspective on mandatory HIV testing. Simpson & 
Forsyth (2007) surveyed pregnant women and assessed their experiences with and opinion on 





case of mandatory HIV testing and the results may have limited applicability to other 
situations and individuals of differing demographics. Katz (2001) interviewed 32 pregnant 
women who had been offered prenatal screening in Canada. These women were asked about 
their own testing experiences, and their opinion on mandatory testing. However, the 




 Truly understanding patients’ perspectives is the most effective way in creating fully 
informed testing initiatives that can effectively increase testing rates. Considering that the 
HIV/AIDS epidemic continues to be a substantial public health threat, all measures that can 
improve testing rates must be considered. The completed research is significant in that it 
provides unique insight on HIV testing, the patients’ perception of the testing experience, and 
deficiencies in current and proposed testing initiatives. For example, the results of this 
research revealed a high degree of support for mandatory testing initiatives, which is often 
assumed to be a highly unfavorable and controversial testing option. Consequently, these 
results indicate that the public may be more receptive to more drastic changes than most 










CHAPTER 2: SPECIFIC AIMS 
 
Our long-term goal is to increase the rate of HIV testing and awareness of HIV 
serostatus in the Commonwealth of Pennsylvania. The objective of this community-based 
Master’s thesis is to assess patients’ responses to opt-out, incentivized, and anonymous 
mandatory testing to identify factors that would motivate individuals to be tested. The central 
hypothesis is that qualitative, semi-structured interviews of HIV positive patients will reveal 
that incentivized testing is the most appealing to patients. Previous research has shown that 
patients are receptive to physician-initiated HIV tests (i.e. opt-out tests). Thus, the addition of 
an incentive to test patients who do not engage the medical system may increase rates of HIV 
testing in the general public. The rationale for this proposed research is that successful 
identification of these factors will lead to fully informed recommendations and guidelines for 
HIV testing initiatives that can better increase testing rates, raise awareness of serostatus, 
influence future HIV testing initiatives and policy proposals and effectively contain further 
spread of infection. 
We tested our central hypothesis and accomplished the objective of this application 
by assessing patients’ responses in a semi-structured interview using open-ended questions to 
elicit elaborated responses. The following three specific aims were pursued: 
  
1. Specific Aim 1: Assess HIV positive and negative patients’ attitudes towards 
opt-out HIV testing.  
The working hypothesis is that patients will be accepting of opt-out testing, as 





2. Specific Aim 2: Assess HIV positive and negative patients’ attitudes towards 
incentivized HIV testing. 
The working hypothesis is that patients will show a positive response to 
incentivized HIV testing.  
3. Specific Aim 3: Assess HIV positive and negative patients’ attitudes towards 
mandatory HIV testing. 
The working hypothesis is that patients will show a negative response to 






CHAPTER 3: METHODOLOGY 
 
3.1 Overview 
A qualitative study was conducted in which 10 HIV-positive men and women 
between the ages of 18 and 64 were interviewed using a semi-structured interview format. 
Participants were interviewed about their HIV testing history, their opinions towards opt-out, 
incentivized, and mandatory HIV testing, and what recommendations they had to improve 
testing rates in the U.S.  
 
3.2 Subjects 
A sample of 10 HIV-positive patients (8 male, 2 female) between the ages of 18 and 
64 were recruited. Participants were currently receiving care from Drexel University College 
of Medicine’s Partnership Comprehensive Care Clinic located in the Center City district of 
Philadelphia, Pennsylvania. HIV status was determined via patient self-reporting; 
participants were not required to provide documentation or obtain an HIV test to participate 
in the study. Criteria for inclusion were being between the ages of 18 and 64, reporting a 
positive HIV diagnosis, and being available to complete the 30-45 minute long interview. 
Criteria for exclusion were any medical condition which rendered the participant unable to 
complete the study, interfered with participation, or posed significant risk to the subject. 
Provisions were made in case of participants who do experience psychological and/or 
emotional distress in response to a particular question or topic. Participants were reassured 
that they could skip questions that they did not feel comfortable answering, and had the 





with a mental health professional.  Subjects were recruited through their physician to 
preserve patient anonymity. Physicians were approached and asked to broach the research 
topic with their patient and provide an informational flyer (Appendix C).  
A total of 19 individuals were approached to participate in the study. Six individuals 
had declined to participate. Three individuals agreed to participate but were not interviewed 
because they did not return to complete the interview at the arranged date and time. Of these 
three individuals, two were lost to consent. These two subjects had completed the consent 
process and requested to return at a later date to conduct the interview. However, they did not 
return at the scheduled date and time for their interview.   
 
3.3 Data Collection  
Face to face interviews were conducted in a private room using a semi-structured 
interview format (Appendix D). All interviews were audio recorded. Questions were 
designed to illicit open-ended answers. Additional probing questions were utilized as needed 
to encourage participants to further elaborate or clarify their responses. Participants were 
asked questions regarding their HIV testing history, their opinions on opt-out, incentivized, 
and mandatory testing, and additional things that could be done to encourage individuals to 
obtain an HIV test. During the interview, subjects were referred to either by a nickname of 
their choosing or their subject identification number. Upon completion of the interview, 
participants were provided $10 compensation for their time. The recorded interviews were 







3.4 Data Analysis 
Interview transcripts were independently analyzed by the research team to identify 
major themes using grounded theory. Grounded theory is a qualitative data analysis 
technique that develops theory from the data rather than testing a preconceived theory via 
collected data (Glaser & Strauss, 1967). The main goal of grounded theory is to ultimately 
produce a theory that explains observed phenomenon (Glaser & Strauss, 1967). We chose to 
use grounded theory approach for data analysis to ensure that the resultant theory is as true to 
the data as possible and to avoid potential bias. Other methods of data analysis were not 
chosen because they are not as true to the data as grounded theory. Content analysis, another 
data analysis methodology, also employs coding to determine emergent themes. However, 
under content analysis data coding is mostly theory driven. Though content analysis can use 
emergent coding where the coding scheme is established based on preliminary analysis of the 
data, this method of data analysis may not be as faithful to the data and can be influenced by 
prior beliefs and ideas (Stemler, 2001).  
The grounded theory approach to data analysis proceeds through four steps (Figure 2, 
Appendix B). The first step is open coding where the transcribed interviews are 
conceptualized for patterns or major events. A conceptual label, or “code,” is applied to the 
identified pattern or major event. All patterns and major events were grouped together by 
their codes. The second step was developing concepts that summarized the patterns identified 
in the transcripts. The third step was elevation of concepts into categories. During this step, 
concepts are grouped and classified into higher level, more abstract categories. The fourth 
step is development of major themes. During development of themes, the categories are 





Finally, a major theory is developed that explains why key relationships between themes 
exist and the meaning behind them.  
 
3.5 Institutional Review Board Approval 
This study was approved by Drexel University’s Office of Regulatory Research Compliance. 
All subjects read and signed an informed consent form (Appendix F), which was kept in a 
locked filing cabinet in a locked office to ensure confidentiality and protection of 
participants’ personally identifiable health information. All transcripts of the interviews were 
kept de-identified.  
 
 
CHAPTER 4: RESULTS 
4.1 Patient Demographics 
Demographic characteristics of the participants are presented in Table 2 (Appendix 
A). The average age was 43.6 ± 7.32 years old, and the average length of time since they 
were diagnosed as HIV-positive to the present day was 11.3 ± 7.26 years. The average length 
of time from diagnosis to initiation of treatment was 9.27 years, with a range from 1 month to 
15 years. All participants were currently receiving care at the Drexel University College of 
Medicine Partnership Comprehensive Care Clinic.  
 
4.2. Patients’ HIV Testing Experiences and Opinions on Testing Initiatives 
 Analysis of the interviews yielded seven major themes, which are discussed below. 





tested, their testing experience, their reactions to their test results, their opinions on the HIV 
testing models (opt-out, incentivized, and mandatory testing), and which model they felt 
would be best to increase testing rates.  
 
4.2.1 Testing Factors 
The first theme identified was testing factors. These are modifying factors that 
influence an individual’s decision to get tested. There were two categories of factors, 
intrinsic and extrinsic, that affected participants’ testing behaviors.  
Half of the participants were first tested for HIV due to intrinsic factors. Participants 
described concern over physical health (either prompted by an illness or a desire to prevent 
disease contraction and transmission) as their reason for testing. For instance, “I was feeling 
sick, I wasn’t feeling so well so I went to the doctor to find out what was wrong,” or “It was 
more to see if I was okay, but I just didn’t want to pass anything along to anybody.” 
 Other participants discussed perceiving oneself to already be at risk for contracting 
the disease as their reason for getting tested. “One time I really took a test because I was sick. 
And uh I knew that in my mind I was being destructive and doing destructive behaviors, 
sexual behaviors, not protecting myself.” Another participant stated, “Um when I first got 
tested I was kind of nervous because I knew that I may have the disease and I was kind of 
scared.” 
The other half of the participants were first tested for HIV due to extrinsic factors, 
meaning they did not proactively request an HIV test but instead were in a situation where 
HIV testing was being performed. One participant received testing through blood donation. 





research study. Another participant was tested due to hospitalization, but could not remember 
if he had consented to take the test. 
 
4.2.2 Reactions to Test Results 
 The second theme was one of negative defense mechanisms in response to 
participants’ HIV positive test results. These defense mechanisms consist of emotional 
reactions and utilization of coping mechanisms. All participants expressed negative 
emotional reactions to diagnosis. Participants expressed feelings of depression, and viewing 
their positive diagnosis as a death sentence. One individual described, “I felt like that was the 
end of my life,” “It was like the end of something.” Two participants expressed feelings of 
isolation, with one exclaiming “you feel….like a leper,” and the other explaining that “I feel 
as though, I don’t know, that there’s not a person out there for me now.” Four participants 
described negative coping mechanisms. These coping mechanisms consisted of denial about 
positive test result and refusal to come to terms with the diagnosis. One participant stated “I 
just medicated myself through the whole thing,” and another described that they felt that 
“there ain’t nothing wrong with me.” Two participants coped by distracting themselves 
through involvement in other activities. One explained that she “just buried [herself] in 
programs in getting people how to you know, be safe, encouraging people to get tested.” The 
other participant stated that he “just kept [himself] busy with the prison program.” 
 
 4.2.3 Testing Experiences 
 The third theme was testing experiences. Testing experience were events that 





difficulties, and receiving pretest counseling. Participants explained that they had 
experienced difficulty in getting tested due to stigmatization. One participant captured this 
feeling of shame when he explained “you wanted to have a coat over your head because you 
didn't want nobody to know.” 
 Half of the participants (n=5) did not receive pretest counseling. Four participants did 
receive pretest counseling. One participant could not remember if he received pretest 
counseling because as described, “everything was so overwhelming to me that if they did do 
that with me, I didn’t…I wasn’t… it just went in one ear and out the other.”  
 Though many of the participants did not receive pretest counseling, all participants 
expressed the need to continue to have counseling at some point during the testing process. 
One participant explained that counseling was needed because the people being tested “need 
to know that it’s not going to be the end of the world.” Others expressed that counseling was 
important so that individuals will know and understand the implications of testing positive, 
and that counseling is needed as a source of support and comfort.  
 
 4.2.4 Opt-Out Testing Seen as Beneficial 
 The fourth theme was opt-out testing seen as beneficial. All participants were 
receptive to opt-out testing and felt that this testing model would help encourage people to 
test. Their positive responses to opt-out testing centered on the idea that any method that 
would streamline the testing process would help increase the number of people tested for 
HIV. For example, one participant remarked about testing that “anything that makes it easier 
and more accessible is going to be helpful.” Another participant explained that opt-out testing 





Moreover, making HIV testing as part of a routine physical was also appealing. One 
participant stated “Yeah, I think I prefer this, just to make it normal routine to encourage 
people to do it every, just you go normally… like dental you have to go every 6 months.”  
 It was interesting to note that one participant cautioned that though opt-out testing is 
beneficial because it makes the testing process easier, the individuals who do refuse to take 
the HIV test may be problematic. This participant explained that “my first thought is anyone 
that would opt-out of…not wanting to be tested for HIV is someone that needs to be tested 
for HIV.” He further stated that “if someone opts out it should be mandatory at that point that 
they get tested.”  Meaning, the individuals who refuse to take an HIV test are the ones who 
are at risk, could potentially already be infected, and need to be tested but do not want to deal 
with the implications of an HIV positive diagnosis. 
 When participants were questioned about specific provisions of opt-out testing (e.g. 
removal of separate written informed consent requirement), all participants felt that removing 
paperwork would help increase the testing rates. Removal of paperwork would be beneficial 
because, as one participant described it, “that paperwork is aggravating, frustrating” and that 
“all that paperwork really will make a person not want to be involved with it.” Participants 
felt that verbal consent is sufficient. As long as a patient is given the opportunity to consent 
in some way, participants found removal of written informed consent acceptable.  
 
 4.2.5 Testing Barriers 
 The fifth theme was testing barriers. Participants’ responses regarding testing barriers 
fell into two general categories: the need for absolution of responsibility and lack of 





because they are afraid of the consequences of a positive HIV test result and do not want to 
have to deal with those implications. A participant stated that “there’s a reason why they’re 
not aware. They don’t want to be aware as long as they feel okay, they’re not going to say 
anything because of the stigma.” Moreover, by not testing people do not have to cope with 
changing their lifestyle according to their serostatus. One participant explained that “being 
negative you get a lot more action.” Another participant touched on the criminalization of 
HIV transmission. He stated:  
 
“Say I have sex with a girl. And I don’t know I have AIDS and I give it to her, right. 
Can I still be charged with attempted murder? No, right? I have to know I have it. So 
see that right there is a deterrence for some people.” 
 
 Another reason that people do not get tested is because of a lack of knowledge about 
the disease, and fear of the disease that stems from this lack of knowledge. One participant 
stated that “You gotta be closer to a cure for people to want to get tested. And, and have 
people realize that it's not a death sentence. You can live with it.” People are also afraid to 
get tested because of the severe stigma that still exists surrounding the disease and the 
ostracization of HIV positive individuals due to the lack of knowledge about the disease in 
the general public. One participant stated that “these groups look down significantly on 







4.2.6 Incentivized Testing 
 The sixth theme was participants’ opinion on incentivized testing. Participants’ 
responses to incentivized testing fell into two categories of pragmatism and idealism. Some 
participants felt that incentivized testing will work in motivating people to test because, as 
one participant put it, “I think it’s an attraction to get your information across.” Participants 
explained that the reason why incentives work is because a person would be willing to take a 
test as long as they are “getting something in return.” Participants felt that incentives would 
help individuals go through with testing out of the desire to get the incentive. One participant 
exclaimed that “it would spark my interest enough to go ahead and see about my health.”  
 However, participants also recognized that it was “a shame to have to pay people to 
be proactive and concerned about their own health.” One exclaimed, “why pay me to go take 
a test? It’s for my health, it’s for my benefit.” Another stated that “it shouldn’t be necessary 
for people to be paid to find out if they have HIV or AIDS because it’s your life.” 
Participants also stated that testing for HIV ideally should be free of coercion, and 
participants recognized that incentivized testing was still a form of coercion. One participant 
framed the incentive as “taking a bribe. Somebody bribe me. If you do this I’ll give you that, 
okay.” Participants also noted that if incentivized testing is going to be used, incentives 
should only be a small amount of money, about $5 to $10. It was stressed to “go the most 
inexpensive way” to avoid coercion. Also, one participant expressed concern that 
incentivized testing would not be effective because it would not encourage individuals with 
high risk behaviors. He stated “you’ll probably get a bunch of people who don’t have it that 






 4.2.7 Types of Incentives 
 When participants were questioned about what type of incentives would be best to 
give to people, their responses fell into two categories: entertainment-type incentives and 
incentives for basic necessities. Entertainment-type incentives included movie tickets and 
basketball tickets while incentives for basic necessities included free health exams, and 
money or vouchers for food or groceries. 
 
 4.2.8 Opinion on Mandatory Testing 
 The seventh theme was participants’ opinions on mandatory testing. Participants were 
asked their opinion regarding this type of testing, and Connecticut’s legislation requiring all 
pregnant women to be tested for HIV was discussed. Their responses fell into one of two 
categories: support for mandatory testing due to the need for desperate measures to contain 
the epidemic and the need to respect autonomy. One participant’s response captured the 
feeling that drastic measures would be required to curb the HIV epidemic. He exclaimed “it’s 
got to become a mandatory test. You want to end it? Make it a mandatory test.” Another 
participant echoed the importance of getting tested when he explained “people need to know 
if they’re HIV positive or negative because it’s an epidemic.” Others described the need to 
get people to test for their health and the health of others. For example, “It’s nothing to be 
ashamed of, it’s just a health, just to find out. It’s our life, it’s my life, so I think it’s 






“if you’re not going to do what you need to for yourself, like get tested, then you 
should…it should be mandatory to get tested to make sure that one you’re okay for 
your own self but as a protection to the other people around.” 
 
Some participants were supportive of mandatory HIV testing under certain 
conditions. For example, “That should be mandatory for pregnant women because why give 
birth to a child that’s going to live with HIV? You know, that’s like…it’s not fair to the child. 
It’s not,” or “They should be mandatory when you go to prison, and if you’re going to rehab. 
If you’re on any kind of government assistance.” Mandatory testing was also acceptable with 
consideration for confidentiality of test results. For example, one participant explained that 
he had no problem with mandatory testing “as long as it’s confidential.” 
 There were participants who were against mandatory testing because they felt that it 
violated patient autonomy. They felt that mandatory testing was “interfering with someone's 
rights.” One participant stated, “It’s their choice if they want to get tested or not. You know, 
do I agree with it? No. No, but it’s their choice.”  
 
 4.2.9 Mandatory Testing Examples 
 Participants were asked to generate examples of mandatory testing that they felt 
would work. Their responses fell into one of two categories: 1) mandatory testing in health 
settings or 2) in government settings. Participants exclaimed that mandatory testing should be 
done as part of an annual physical, or mandate that all individuals who enter the hospital 





testing to drivers’ license renewals, filing tax returns, incarceration in local and federal 
prisons, and job interviews. 
 
4.2.10 Most Effective Testing Model 
 Out of all three testing models that participants were interviewed for their opinions, 
both mandatory testing and opt-out testing were indicated as the most effective in getting 
people to test for HIV. Three out of the ten participants indicated mandatory testing as most 
effective over the other two testing models. Three participants named opt-out testing the most 
effective. Two participants claimed incentivized as the most effective. One participant did 
not have a clear indication of opt-out or incentivized being more effective than the other, but 
he did not agree with mandatory testing. One participant stated liking both opt-out and 
incentivized equally, and preferred mandatory testing as long as test results were confidential 
but felt that it would not be possible to implement it.  
It is important to take note that of the three participants who selected opt-out testing 
as most effective, two participants felt that testing should be mandatory, but did not select 
mandatory as the most effective testing model because they felt that it would never be 
implemented due to overwhelming resistance from the general public to such a mandate. 
 
 4.2.11 Participant-Generated Alternatives to Increase Testing Rates 
 When participants were asked to generate other alternatives to increase testing rates, 
their responses fell into two categories: increase testing rates via active or passive 
recruitment. Active recruitment involve events that are proactively reaching out to the 





locations. This type of recruitment involves more direct person-to-person contact. 
Participants listed conducting community events such as health fairs, conducting testing 
follow-ups, conducting testing at bars, and performing community-based projects. 
 Passive recruitment involves methods that provide information to a widespread 
audience and do not involve direct contact with individuals to increase awareness about 
testing and testing locations. Participants listed posting advertisements at bus stops or on 
billboards, airing public service announcements on radio or TV media, and placing postcards 
in the mail.  
 
 
CHAPTER 5: DISCUSSION 
 
This study identified both mandatory and opt-out testing as the model that 
participants identified as the best model to improve testing rates. An equal number of 
participants chose mandatory as opt-out. Participants who felt that mandatory testing was 
best was because of the severity of the HIV epidemic and the need for desperate measures to 
curb the spread of the disease. Participants also emphasized that it was extremely important 
for individuals to know their HIV status because they believed that it was individuals’ lack of 
awareness about their status that increases transmission of this disease. Participants felt that 
the major reason individuals did not test was because they did not want to cope with the 
implications of a positive test result and the potential social isolation due to the stigma 






5.1 Opt-Out Testing 
The findings of this study regarding patient’s attitudes towards opt-out testing are in 
agreement with existing studies that indicate that patients are receptive towards physician-
initiated HIV testing (Haukoos et al., 2008; Burrage et al., 2008; Corneli et al., 2008). 
Patients are in general trusting of their doctors and most comply with physician-
recommended actions.   
Participants also felt that removal of separate written informed consent would ease 
the testing process and encourage more people to test, which is in agreement with the 
findings of Zetola et al. (2008), and the initial intent of the CDC when these updated testing 
recommendations were created. In Zetola et al.’s study, the average monthly rate of HIV tests 
per 1000 patients increased by 44%, and the monthly average number of new HIV positive 
test results increased by 67% with the removal of the separate written informed consent. 
 
5.2 Incentivized Testing 
Though there is no research on patients’ perspectives on incentivized testing, the 
finding that participants were amenable to incentivized testing parallels the success of using 
incentives to encourage compliance with outpatient testing referrals.  
 
5.3 Mandatory Testing 
The degree to which patients were supportive of mandatory testing was unexpected. 
The high number of participants choosing mandatory testing indicates that these participants 
recognize the urgency of the HIV epidemic situation and the importance of serostatus 





testing may also be influenced by their positive diagnosis. Familiarity with the disease and 
the severity of its effect on a person’s health may have caused some participants to be more 
amenable to more aggressive means of increasing testing rates.  
 
5.4 Lack of Awareness about HIV/AIDS 
 Many participants emphasized that there is limited awareness of HIV/AIDS currently 
compared to when they were first tested for the disease. All participants indicated some form 
of education campaign when asked for alternative methods to increase testing rates. Their 
observations were reflected in a recent nationwide Kaiser Family Foundation survey (2009b). 
The results of this survey indicated that the percent of individuals who had personally seen, 
heard, or read about the problems of AIDS in the U.S. had fallen from 34% in 2005 to 14% 
in 2009. Moreover, the percent of individuals who had “heard nothing at all” about AIDS 
increased from 4% to 12%. Those who had heard only a little increased by 18% from 25% in 
2004 to 42% in 2009. Interestingly, health officials recognized this increasing sense of 
complacency and the White House, HHS, and CDC recently launched a five-year HIV/AIDS 
awareness campaign titled “Act Against AIDS.” The goal of this initiative is to educate the 
public that every nine and a half minutes someone is infected with HIV and also provide 
information on testing locations and resources (Kaiser Daily HIV/AIDS Report, 2009). 
 
5.5 Patient Reactions to HIV Diagnosis 
All patients had negative emotional reactions to their HIV positive diagnosis. Patients 
described that they were in shock, and many described being in denial and not coming to 





of a positive HIV diagnosis and initiation of treatment. The length of time ranged from as 
little as 1 month to as long as 15 years, with the average length of time being 9.27 years. 
 These patients’ reactions to their diagnosis are similar to the Kubler-Ross model 
(1969) of the process by which individuals deal with grief and tragedy by progressing 
through five stages: denial, anger, bargaining, depression, and acceptance. According to 
Kubler-Ross, patients will let go of their denial and use less radical defense mechanisms 
depending on how patients were told about their diagnosis, how much time patients have to 
acknowledge their illness or situation, and how their life experiences have prepared them to 
cope with stressful situations.  
A considerable proportion of study participants were from low socioeconomic 
backgrounds; 40% of these participants had at most attained a high school education. 
Moreover, the majority of patients did not receive pretest counseling or any form of 
counseling, and had received their test results in a direct manner partially due to the 
conditions in which they were tested. These factors may have contributed to the long length 
of time between diagnosis and treatment because participants were not equipped with healthy 
coping mechanisms based on previous life experiences. In addition, the fact that HIV can 
remain dormant without any noticeable or severe effects on an individual’s health could also 
contribute to the difficulty with which participants may have had in coping with their 
diagnosis and seeking treatment.  
The severe social stigma and resultant fear and isolation towards HIV positive 
individuals may also have impeded these participants’ health-seeking behaviors. Most 
participants were first tested for HIV during the late 1980’s and early 1990’s. During that 





disease and how it is transmitted, and stigma against the disease was much higher back then 
than it is today. The overwhelmingly negative public attitude towards HIV/AIDS may also 
have contributed to participants’ aversion to seeking treatment and coming to terms with 
their diagnosis.  
   
5.6 Limitations 
 The small sample size and the demographics of the sample place limitations on the 
generalizability of these findings to other settings. The majority of participants were African-
American males who had at most a high school education, annual family incomes of less than 
$20,000, were unemployed and were publicly insured. Moreover, participants were all HIV 
positive. Their familiarity with and acceptance of the disease may have skewed their 
responses in favor of more drastic testing methods because they have first-hand experience 
with the severity of the disease. Self-selection of participants may also have biased the 
sample. Meaning, participants who had strong feelings regarding HIV testing that might not 
be representative of the general population or of the HIV positive population were more 
likely to volunteer to participate in the study than others who are more ambivalent towards 
HIV testing. 
Moreover, only HIV positive patients’ perspectives were included in this report. The 
original research proposal did include HIV negative patients, and data were collected for this 
population. However, due to time constraints their data were not included in this report.   
Recall bias, which is subjects’ misremembering some facts, and social desirability 
bias, which is the subjects’ desire to not be viewed negatively by the interviewer, may also 





responded in the way that they believed is “socially acceptable.” For example, some 
participants had initially stated that they believed mandatory testing was fair, but upon 
further probing had changed their mind and stated that they did not believe it was fair and 
that it interfered with an individual’s right to choice. Thus, the participant may have felt that 
it was wrong to believe that it was acceptable to encroach on an individual’s civil liberties for 
the sake of increasing HIV testing rates and either expressed discreet support for mandatory 
testing or decided to not express their support at all. Some participants also either did not 
fully understand the questions that were asked or misinterpreted them, and the interviewer 
did not catch that they had misinterpreted the question or did not fully answer the question 
until after the interview had concluded.  
Interviewer bias, as to the manner in which the interviewer phrased the question or 
the interviewer’s tone of voice, may also have consciously or subconsciously influenced the 
participant’s responses. For example, the interviewer had asked participants if they thought 
mandatory testing was fair. This phrasing of the question may have led participants to believe 
that they were not supposed to answer that mandatory testing was fair. Interviewer bias can 
be addressed through usage of computerized interviews. The benefit of this type of interview 
is that it allows for uniform phrasing and presentation of questions and does not let verbal or 
nonverbal cues from the interviewer to influence responses (Bachman, 2003). Moreover, 
patients may feel more comfortable when answering controversial questions and thus be 
more likely to provide answers closer to their true beliefs and attitudes. However, 
computerized interviews cannot detect nonverbal responses such as body language that may 






CHAPTER 6: CONCLUSION 
  
6.1 Future Research  
Considering the small sample size and limited generalizability of these findings, 
future research should be conducted with larger sample sizes that also include HIV negative 
populations, and individuals from a wider range of socioeconomic and racial/ethnic 
backgrounds. Other healthcare settings should also be included considering that the 
characteristics of patients receiving care from, for example, private physician office settings, 
will be different from those of clinics in academic settings.  
Future research directions may also investigate patients’ perspectives on 
criminalization of HIV transmission and its effect on HIV testing behaviors. Criminalization 
of HIV transmission has been a recent development in the news media. For example, a man 
in Iowa was recently sentenced to 25 years in prison for not disclosing his HIV status and 
knowingly transmitting the disease to another individual (Stegmeir, 2009). Moreover, this 
man was required to register as a sex offender and undergo a sex offender treatment program, 
and was also given a five-year no contact order with the victim. The significant penalties 
associated with knowingly transmitting HIV may have a negative impact on HIV testing 
because individuals may become unwilling to test due to the implications associated with 
serostatus awareness. 
 
6.2 Policy Recommendations  
This study has important clinical and public health policy implications. Considering 





mandatory testing, a good first step to bolster current CDC opt-out testing recommendations 
would be to mandate that all physicians must test their patients at their annual physicals, and 
all emergency room admissions must be screened on an opt-out basis.  
  
6.2.1. Addressing HIV/AIDS Complacency 
It is also crucial to address the increasing sense of complacency in the U.S. regarding 
HIV/AIDS. Many are not as aware about HIV/AIDS and do not believe that it is a significant 
health problem anymore. In a recent survey conducted by the Kaiser Family Foundation 
(2009), the percentage of Americans who named HIV as the most urgent health problem 
facing the nation decreased from 44% in 1995 to 6% in 2009 (Figure 3, Appendix B). 
However, recent studies by the CDC (2008) indicated that the annual rate of new HIV 
infections in the U.S. were over 40% higher than previously estimated.  
This discordance between increasing infection rates and increasing complacency 
about the disease will only exacerbate the epidemic unless the problem is addressed. The 
recently launched campaign by the White House, HHS, and CDC is a good first step to 
combat low awareness. Hopefully the five-year program will result in increased testing rates. 
However, it is important to emphasize that awareness campaigns must not be cyclical and 
reactive. In order to contain the current HIV/AIDS epidemic, awareness campaigns must be 
constant so that individuals are always receiving information about the severity of the 
disease. One important barrier to testing that participants had described was the idea that 
many people believe that they are not at risk, that because they “feel fine” they do not need to 
be tested. Another is stigma. However, awareness campaigns will help in combating these 





the advent of new medical and pharmaceutical advances, the disease is no longer a death 
sentence.  
  
6.2.2. Ensuring Adequate Financing of Routine HIV Screening 
 Though the CDC has recommended that all healthcare settings conduct routine opt-
out testing and several states have legislation that facilitate opt-out testing, the issue of 
financing expanded HIV testing may also complicate the ability of healthcare facilities to 
comply with these recommendations. A recent review conducted by Burke et al. (2007) 
indicated that inadequate reimbursement was one barrier that physicians had indicated as a 
barrier to offering HIV tests to their patients.  
A potential method to address reimbursement issues is to advocate for amendment of 
the federal Employee Retirement Income Security Act of 1974 (ERISA) to include HIV 
testing as one of the benefits covered by ERISA plans. ERISA is a federal statute that 
stipulates minimum standards for all employee pensions, health, and other benefits plans that 
are offered by private-sector employers or unions (National Academy for State Health 
Policy, 2000). Unfortunately, amendment of ERISA would not benefit uninsured or self-
insured individuals.   
Another method would be to advocate for states to pass a bill in similar fashion to 
California that requires all health service plans and insurers to cover HIV testing. In October 
2008, California signed into law AB 1894 that mandated that all health service plans and 
insurers cover HIV testing (Cathcart, 2008). Under this bill HIV testing also becomes a 






6.2.3. Ensuring Access to Care and Treatment  
Another aspect that must be addressed and researched in the future is ensuring that in 
parallel with widespread testing, healthcare settings are able to provide treatment or 
sufficient linkage to treatment resources and referrals for those who test positive. It is 
estimated that of the 1.2 million people living with HIV/AIDS today, approximately half of 
them are not receiving care for their disease (Kates and Levi, 2007). If an increasing number 
of undiagnosed HIV positive individuals are being identified, current available resources 
might not be able to support this influx of new patients.  
Moreover, we must also ensure that treatment is affordable for these patients as it is 
unethical to diagnose someone with a disease and not also provide an avenue for treatment. A 
typical antiretroviral drug regimen costs approximately $14,000-$15,000 per person per year 
(Kaiser Family Foundation, 2006). This estimate does not include costs for other types of 
drugs that PLWH may need for other concomitant health conditions. PLWHA are more 
likely to be uninsured or covered by public insurance (Medicaid and/or Medicare), be 
unemployed or have annual incomes that are less than $10,000 (Schiller, 2001; Kaiser 
Family Foundation, 2008b). Thus, a large proportion of PLWH do not have the means to pay 
for their care on their own. States will need to examine the funds earmarked for AIDS Drug 
Assistance Programs (ADAP), which provide HIV prescription drugs for low-income 
individuals with limited or no prescription drug coverage.  
Moreover, the federal government should consider passing a recently introduced bill, 
titled Early Treatment for HIV Act (ETHA), which would allow states to expand Medicaid 
coverage for HIV-positive individuals through an enhanced federal matching rate. Current 





disabled, which is defined as having AIDS and becoming disabled by this disease. 
Previously, when Social Security first classified AIDS as a disability, successful treatment 
for HIV/AIDS did not exist (Kaiser Family Foundation, 2008b). This portion of the 
legislation is unfortunate because early treatment initiation can prevent irreversible immune 
system damage and result in improved healthcare outcomes.  
 HIV/AIDS continues to be a significant public health problem in the United States. 
Current testing initiatives are heading in the right direction, but more must be done to ensure 
that more individuals are tested for this disease at least once in their lifetimes. Since the 
beginning of the epidemic, HIV has been highly stigmatized making it difficult to fully 
address the social and environmental factors influencing transmission and treatment seeking 
behaviors. Nevertheless, all future testing initiatives must find that balance between 
encouraging and promoting widespread routine testing, ensuring confidentiality of results 
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APPENDIX A: TABLES 
 
 
Table 1. Updated CDC HIV Testing Recommendations 
Non-pregnant Adults and Adolescents 
 
• Routine, voluntary screening for all individuals 13-64 years old, 
not based on risk 
• Repeat annual testing for persons with known risk 
• Screening performed on opt-out basis, patients still have 
opportunity to ask questions and decline testing 
• Pre-test prevention counseling no longer required 
• Separate written informed consent no longer required, verbal 
consent is sufficient 
• General consent for care considered sufficient as long as patient 
is told HIV testing may be included 





• Universal opt-out screening 
o HIV testing included in panel of prenatal screening tests 
o Consent for prenatal care includes HIV testing 
o Patient provided opportunity to decline testing 
• Second test during third trimester of pregnancy for women who 
are at risk or are receiving care in a high-prevalence healthcare 
facility 
• Opt-out rapid testing for women of undocumented HIV 
serostatus in labor or delivery 








Table 2. Demographics of interviewed participants 
Race N % 
 Black 8 80 
 White 2 20 
 Other 0 0 
Gender   
 Male 8 80 
 Female 2 20 
Insurance Status   
 Public 7 70 
 Private 1 10 
 Uninsured 2 20 
Highest Level of Education Completed   
 Less than High School 2 20 
 High School or GED 4 40 
 Some College 2 20 
 College 2 20 
 Advanced Degree 0 0 
Annual Family Income   
 Less than $20,000 7 70 
 $20,000—$50,000 2 20 
 $50,000—$100,000 0 0 
 Greater than $100,000 1 10 
Employment Status   
 Employed 1 10 
































































Figure 3. Decreasing percentage of Americans who name HIV as most urgent health problem. 













APPENDIX D: SEMI-STRUCTURED INTERVIEW QUESTIONS 
 
Patients will first be provided an overview of the purpose of study.  
Introductory statement: “Thank you for your willingness to participate in this research 
study today. Before we begin, I will first explain to you a little bit about the purpose of this 
study and what we’ll be discussing today. Please feel free to stop me at any time if you have 
any questions, would like me to clarify anything, or would like to withdraw from the study. 
Please know that withdrawing from the study will not in any way affect the care that you 
currently receive from the clinic.  
 “The purpose of today’s study is to determine which features of certain types of HIV 
testing are most appealing to patients. We hope to use this information to generate 
recommendations for future HIV testing initiatives so that ultimately we can decrease the rate 
of new HIV infections in the U.S. 
 “Today I will be asking you questions about your HIV testing history (if the 
participant is HIV positive), go over with you current types of HIV testing models, and ask 
you for your opinion about these testing models. Are there any questions you would like to 
ask before we begin?”  
 
 
HIV Testing History 
Could you tell me a little about the circumstances surrounding when you were first tested? 
 Where did you obtain your test? 
 How long ago was the test? 
 Anonymous or confidential test? 
What motivated you to get tested? 
 When you received your test result, how did you feel? 
Do you obtain tests regularly? 
  If yes, why? 
 Did you experience any difficulty in getting tested? 
  If yes, can you list and explain them? 
 Did you receive any type of pre and/or post-test counseling? 
  If yes, did you feel that it was or was not helpful/beneficial? 
 
Changes in CDC Recommendations 
 Recently in 2006, the Center for Disease Control (CDC) changed its 
recommendations for HIV testing. Under the old CDC recommendations, HIV testing was 
conducted on a voluntary, opt-in basis with counseling and testing linked together (also 
called voluntary counseling and testing or VCT). Under VCT, a patient would have to 
specifically request for an HIV test, provide written consent, and undergo pretest counseling. 
However, the CDC felt that these requirements were themselves a significant barrier to 
widespread testing, and to obtaining an HIV test in general. So, with the new 
recommendations, all patients are tested on an opt-out basis where you are told that an HIV 
test will be performed and consent is understood unless you specifically decline the test. 





get pre-test counseling where their physician would discuss with them ways to reduce risky 
behaviors that would increase their risk in contracting HIV. 
 
o Were you aware of these changes? 
o Why do you feel these changes were made, and what is the purpose of these 
changes?  
o What is your opinion on these changes? 
 probe as needed: ask about removal of pretest requirement, informed 
consent.  
o Do you feel these changes will motivate more people to get tested? Please 
explain your answer 
  
Alternatives to Opt-Out 
Incentivized Testing 
Other than opt-out, some groups have tried incentivized testing to increase testing 
rates. One example of incentivized testing is providing someone with a gift card to a grocery 
store for completing an HIV test. 
 
o Do you feel that incentives will increase number of people who get tested? 
Why? 
o List types of incentives- gift card to grocery store, concert tickets, money. 
Which one do you feel will motivate people to get tested? Why? 
o Would you list a few that you believe would be successful? 
 
Mandatory testing 
Another alternative testing method is mandatory testing. Under mandatory testing, 
people are required to obtain an HIV test. One current example is Connecticut, which 
requires all pregnant women to get tested. Another example is one where individuals would 
not be able to file their income tax form unless they have proof that they had taken an HIV 
test. The individual could go to an HIV clinic, take a test, and receive a 10 digit number that 
they would write down on their income tax form. The IRS would not know the result of the 
HIV test, just the fact that you had taken one. 
  
o What is your opinion on mandatory testing? Anonymous mandatory testing? 
o Do you think it is fair?  
o Do you feel that mandatory testing will be successful in increasing number of 
people who get tested? 
o Other than the examples of mandatory testing that I have listed, are there any 
that you feel would be successful?  
  
Ending the Interview  
 Before we wrap up this interview, would you be willing to provide me some general 
information about yourself, such as your age and so forth? 
 
Obtain Patient Demographics 







Insurance status: private, public (Medicaid), uninsured 
Family income: below $20,000; $20,000- $50,000; $50,000-$100,000; above $100,000 
Highest level of education completed:  less than 8th grade; some high school; high school or 
GED; some college; college; graduate school 
Employment status: employed, unemployed 
 
 Thank you again for your time and willingness to speak with me today. Do you have 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX F: IRB CONSENT FORM 
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